title: TNF inhibitors for uveitis: balancing efficacy and safety.
authors.forename: Emmett T
authors.initials: ET
authors.lastname: Cunningham
authors.forename: Manfred
authors.initials: M
authors.lastname: Zierhut
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003711:Demyelinating Diseases / Q000139:chemically induced; D006801:Humans; D000069285:Infliximab; D009902:Optic Neuritis / Q000139:chemically induced; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab